Officiële publicaties Theraclion

Aandelen

Real Time Euronext Paris Andere beurzen 09:00:21 03-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,374 ^EUR	+2,47%		-10,10%	-3,61%

27/03	Theraclion SA rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
2023	Theraclion bereikt een belangrijke mijlpaal op weg naar de Amerikaanse markt: Eerste patiënten behandeld met Sonovein als onderdeel van de door de FDA goedgekeurde pivotale studie	CI

Combined general shareholders meeting	24-05-23	CO
Monthly statement on voting rights	30-04-23	CO
Annual results	28-04-23	CO
Annual results	28-04-23	CO
Financial report	28-04-23	CO
Monthly statement on voting rights	31-03-23	CO
Monthly statement on voting rights	28-02-23	CO
Monthly statement on voting rights	31-01-23	CO
Monthly statement on voting rights	30-11-22	CO
Half-year report	01-11-22	CO
Monthly statement on voting rights	31-10-22	CO
Changes in management and corporate officers	31-10-22	CO
1st-half-year results	26-09-22	CO
1st-half-year results	26-09-22	CO
Monthly statement on voting rights	31-07-22	CO
Monthly statement on voting rights	30-06-22	CO
Monthly statement on voting rights	31-05-22	CO
Monthly statement on voting rights	30-04-22	CO
Monthly statement on voting rights	31-03-22	CO
Corporate officers' Statement : transactions in the company's securities - Purchase	07-03-22	CO
Corporate officers' Statement : -Other Types Operations	07-03-22	CO
Corporate officers' Statement : -Other Types Operations	03-03-22	CO
Corporate officers' Statement -: xercise of Stock Options 4	02-03-22	CO
Minutes of the general assembly	07-02-22	CO
Monthly statement on voting rights	31-01-22	CO